Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
21
CYTK Quote, Financials, Valuation and Earnings
Last price:
$42.91
Seasonality move
:
1.46%
Day range:
$42.86 - $44.68
52-week range:
$40.53 - $75.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
261.78x
P/B ratio:
61.87x
Volume:
1.3M
Avg. volume:
1.9M
1-year change:
-32.11%
Market cap:
$5.1B
Revenue:
$18.5M
EPS (TTM):
-$5.26
Earnings Data
Next earnings date for CYTK
May 08
2025
Most recent earnings per share
-$1.26
Missed by $0.09
(Feb 27/2025)
Consensus Estimate
-$1.17
(Feb 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CYTK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/08/2025 | Q1 | $3.1M | -- | -- | -$1.36 | -- |
| 02/27/2025 | Q4 | $14.3M | $16.9M | -$1.26 | -$1.17 | -$0.09 |
| 11/06/2024 | Q3 | $1.2M | $463K | -$1.36 | -$1.24 | -$0.12 |
| 08/08/2024 | Q2 | $21M | $249K | -$1.31 | -$0.91 | -$0.40 |
| 05/08/2024 | Q1 | $906.6K | $835K | -$1.33 | -$1.17 | -$0.16 |
| 02/27/2024 | Q4 | $13.3M | $1.7M | -$1.38 | -$0.95 | -$0.43 |
| 11/02/2023 | Q3 | -- | -- | -$1.35 | -$0.76 | -$0.59 |
| 08/03/2023 | Q2 | -- | -- | -$1.34 | -$1.24 | -$0.10 |
| 05/04/2023 | Q1 | -- | -- | -$1.38 | -$1.18 | -$0.20 |
| 03/01/2023 | Q4 | -- | -- | -$1.45 | -$1.19 | -$0.26 |
| 11/03/2022 | Q3 | -- | -- | -$1.52 | -$1.17 | -$0.35 |
| 08/04/2022 | Q2 | -- | -- | -$0.23 | -$1.01 | $0.78 |
| 05/04/2022 | Q1 | -- | -- | -$1.05 | -$0.94 | -$0.11 |
| 02/24/2022 | Q4 | -- | -- | -$0.36 | -$0.84 | $0.48 |
| 11/03/2021 | Q3 | -- | -- | -$0.95 | -$0.77 | -$0.18 |
| 08/05/2021 | Q2 | -- | -- | -$0.86 | -$0.66 | -$0.20 |
| 05/06/2021 | Q1 | -- | -- | -$0.66 | -$0.61 | -$0.05 |
| 02/25/2021 | Q4 | -- | -- | -$0.62 | -$0.46 | -$0.16 |
| 11/04/2020 | Q3 | -- | -- | -$0.05 | -$0.34 | $0.29 |
| 08/06/2020 | Q2 | -- | -- | -$0.68 | -$0.57 | -$0.11 |
| 05/06/2020 | Q1 | -- | -- | -$0.66 | -$0.51 | -$0.15 |
| 03/03/2020 | Q4 | -- | -- | -$0.51 | -$0.44 | -$0.07 |
| 10/31/2019 | Q3 | -- | -- | -$0.50 | -$0.49 | -$0.01 |
| 08/08/2019 | Q2 | -- | -- | -- | -$0.50 | -- |
| 05/09/2019 | Q1 | -- | -- | -- | -$0.47 | -- |
| 02/21/2019 | Q4 | -- | -- | -- | -$0.52 | -- |
| 11/01/2018 | Q3 | -- | -- | -- | -$0.52 | -- |
| 07/26/2018 | Q2 | -- | -- | -- | -$0.51 | -- |
| 04/26/2018 | Q1 | -- | -- | -- | -- | -- |
| 02/15/2018 | Q4 | -- | -- | -- | -- | -- |
| 10/26/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/02/2017 | Q2 | -- | -- | -- | -- | -- |
| 04/27/2017 | Q1 | -- | -- | -- | -- | -- |
| 02/16/2017 | Q4 | -- | -- | -- | -- | -- |
| 10/27/2016 | Q3 | -- | -- | -- | -- | -- |
| 07/28/2016 | Q2 | -- | -- | -- | -- | -- |
| 04/28/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/16/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -- | -- | -- |
| 07/29/2015 | Q2 | -- | -- | -- | -- | -- |
| 04/30/2015 | Q1 | -- | -- | -- | -- | -- |
Cytokinetics Earnings Questions
-
How Much did Cytokinetics Generate in Revenue Last Quarter?
Cytokinetics reported $16.9M worth of top line sales in its most recent quarter.
-
Did Cytokinetics Beat Earnings Last Quarter?
Cytokinetics announced earnings per share of -$1.26 which represents a miss of analyst forecast a -$1.17 per share.
-
Is Cytokinetics Profitable?
Cytokinetics reported -$76.7M that represents -$0.65 per share over the last quarter.
-
What is the Analyst Consensus for Cytokinetics EPS Next Year?
Cytokinetics's earnings are forecast to decrease from -$5.26 per share to -$5.16 per share next year representing a decrease of -6.46%.
-
When is Cytokinetics's Earnings Date?
Cytokinetics's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
Buy
93
ESLT alert for Mar 19
Elbit Systems [ESLT] is up 0.57% over the past day.
